NuLeaf Naturals Earns B Corp Certification
DENVER — NuLeaf Naturals, makers of cannabinoid products announced, it has earned B Corporation™ certification. A pioneer in the CBD industry, NuLeaf Naturals joins an elite group of for-profit companies building a more sustainable and inclusive economy.
B Lab, the verifying body behind B Corp, conducted a rigorous and comprehensive evaluation of NuLeaf Naturals’ business practices, products, and adherence to its comprehensive standards. B Corp is comprised of more than 4,000 businesses in over 74 countries across 150 industries, all united to balance purpose with profit. NuLeaf Naturals, along with other companies in the B Corp community such as Patagonia and Ben & Jerry’s, is committed to considering the impact each decision it makes has on employees, customers, suppliers, community, and the environment.
“Achieving B Corp certification was important to NuLeaf Naturals because it aligns with our commitment to creating the highest quality products while reaching the highest verified standards of social and environmental performance, transparency, and accountability,” said Ian Kelly, NuLeaf Naturals’ Chief Executive Officer.
“We are pleased to welcome NuLeaf Naturals into our global community of businesses committed to making positive change for people and the planet,” said Lindsey Wilson, Manager of Business Development at B Lab U.S. & Canada. “B Corp’s goal of using business as a force for good aligns with NuLeaf Naturals’ mission of helping people live a healthier happier lifestyle.”
(This information is primarily sourced from NuLeaf Naturals. Highly Capitalized has neither approved nor disapproved the contents of this news release. Read our Disclaimer here).
Reunion Neuroscience to be Acquired by MPM BioImpact in $13.1 Million All-Cash Deal
LOS ANGELES-- Reunion Neuroscience Inc. a clinical-stage biopharmaceutical company specializing in innovative therapies for underserved mental health conditions, has announced a definitive arrangement agreement with MPM BioImpact, a leading biotechnology investment firm. Under the agreement, ...
California’s Regulated Cannabis Market Sees Decline in Sales and Tax Revenue in Q1 2023
LOS ANGELES-- California's hopes of increased consumer participation in the regulated cannabis market did not translate into a boost in licensed retail sales or state tax revenue during the first quarter of 2023. According to ...
C21 Investments Repays $30 Million Debt to CEO Sonny Newman
LOS ANGELES-- C21 Investments Inc., a vertically integrated cannabis company, announced today the successful completion of the full repayment of its $30 million senior secured note owed to Sonny Newman, the Company's President and Chief ...